Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 24
  • Start Date: January 15, 2020
A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 180
  • Start Date: January 1, 2020
A Study of Efficacy and Safety of Idebenone vs. Placebo in Prodromal Parkinson Disease (SEASEiPPD)
Search for trials
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 80
  • Start Date: May 24, 2019
French Validation of a Severity Scale in REM Sleep Behavior Disorder
Clinical Trial
  • Status: Recruiting
  • Participants: 360
  • Start Date: August 29, 2018
North American Prodromal Synucleinopathy Consortium
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 100
  • Start Date: August 14, 2018
Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease and Controls
Clinical Trial
  • Status: Recruiting
  • Participants: 800
  • Start Date: June 2011
Natural History Study of Synucleinopathies
Clinical Trial
  • Status: Active, not recruiting
  • Participants: 89
  • Start Date: May 27, 2009
Biomarkers of Risk of Parkinson Disease
Showing 1-7 of 7